New quinazolinone derivatives: Synthesis, anti-inflammatory and antitumor activities

International Journal of ChemTech Research

Volumn 2, Issue 3, 2010, Pages 1560-1578

  Abbas, Safinaz E ^a   Gawad, Nagwa M Abdel ^a   Georgey, Hanan H ^a   Abdullah, Jalal H ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Anti inflammatory activity; Antitumor activity; Quinazolinone

Indexed keywords

(4 OXO 2 PHENOXYMETHYL QUINAZOLIN 3(4H) YL CARBAMOYL) METHYL; 3 (4 OXO 2 PHENOXYMETHYL QUINAZOLIN 3(4H) YL) IMIDAZOLE 2,5 DIONE; 3 (4 OXO 4,5 DIHYDRO THIAZOL 2 YLAMINO) 2 PHENOXYMETHYL QUINAZOLIN 4 (3H) ONE; 4(3H) QUINAZOLINONE DERIVATIVE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; DOXORUBICIN; IBUPROFEN; N (4 OXO 2 PHENOXYMETHYL QUINAZOLIN 3(4H) YL) AMIDE; POLYSORBATE 80; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CARCINOMA CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; NONHUMAN; PAW EDEMA; RAT; STANDARD; ULCEROGENESIS;

EID: 77957342612     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Jatav V., Kashaw S. and Mishra P., Synthesis, antibacterial and antifungal activity of some novel 3-[5-(4-substituted phenyl)-1, 3, 4-thiadiazole-2-yl]- 2-styryl quinazoline-4(3H)-ones, Med. Chem. Res., 2008, 17, 169-181.
2. Azab M.E., Kassab E.A., El-Hashash M.A. and Ali R.S., Synthesis and antibacterial activity of some new 4(3H)quinazolin-4-One derivatives. Phosphorus, Sulfur and Silicon., 2009, 184, 610-625.
3. Mathew J.E., Dinakaran V., Kaur N. and Srinivasan K.K., Pharmacological potential of some novel quinazoline-4(3H)-ones, Pharmacologyonline, 2008, 2, 618-623.
4. Pandey S.K., Singh A., Singh A. and Nizamuddin, Antimicrobial studies of some novel quinazolinones fused with [1, 2, 4]-triazole, [1, 2, 4]- triazine and [1, 2, 4, 5]-tetrazine rings, Eur. J Med. Chem., 2009, 44, 1188-1197.
5. Gokhan-Kelekci N., Koyunoglu S., Yabanoglu S., Yelekci K., Ozgen O., Ucar G., Erol K., Kendi E. and Yesilada A., New pyrazoline bearing 4(3H)- quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity, Bioorg. Med. Chem., 2009, 17, 675-689.
6. Abu-Shady H.A., Micheal A.N., Abbas S.E. and. Abu-Youssef H.E., Synthesis of some substituted 4(3H) quinazolinones of diverse biological activities, Egypt. J. Chem., 2007, 50(3), 313-336.
7. Kashaw S.K., Kashwa V., Mishra P. and Jain N.K., Design, synthesis and potential CNS activity of some novel 1-(4-substituted-phenyl)-3-(4-oxo- 2-propyl-4H-quinazolin-3-yl)-urea, Arkivoc, 2008, 14, 17-26.
8. Kashaw S.K., Kashwa V., Mishra P., Jain N. K and Stables J. P., Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl/ethyl- 4H-quinazolin-3-yl)-urea, Eur. J. Med. Chem., 2009, 44, 4335-4343.
9. Mizutani T., Nagase T., Ito S., Miyamoto Y., Tanka T., Takenaga N., Tokita S. and Sato N., Development of novel 2-[4-(aminoalkoxy)- phenyl]-4(3H)-quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists, Bioorg. Med. Chem. Lett., 2008, 18, 6041-6045.
10. Mitobe Y., Ito S., Mizutani T., Nagase T., Sto N. and Tokita S., Development of a selective and potent radioactive ligand for histamine H3 receptors: a compound potentially useful for receptor occupancy studies, Bioorg. Med. Chem. Lett., 2009, 16, 4075-4078.
11. Jatav V., Mishra P., Kashow S. and Stables J.P., CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1, 2, 4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones, 2008, Eur. J. Med. Chem., 43, 1945-1954.
12. Georgey H., Abdel-Gawad N. and Abbas S., Synthesis and anticonvulsant activity of some quinazoline-4-(3H)-one derivatives, Molecules, 2008, 13, 2557-2569.
13. Chen Z., Hu G., Li D., Chen J., Li Y., Zhou H. and Xie Y., Synthesis and vasodilator effect of rutaecarpine analogues which might be involved in transient receptor potential vanilloid subfamily, member 1 (TRPV1), Bioorg. Med. Chem., 2009, 17, 2351-2359.
14. Xue S., McKenna J., Shieh W.C. and Repic O., A facile synthesis of C2, N3-disubstituted-4-quinazolinone, J. Org. Chem., 2004, 69, 6474.
15. Alagarsamy V. and Pathak U.S., Synthesis and antihypertensive activity of novel 3-benzyl-2-substituted-3-H-[1, 2, 4]triazolo[5, 1-b] quinazoline-9-ones, Bioorg. Med. Chem., 2007, 15, 3457-3462.
16. Zabeer A., Bhagat A., Gupta O.P., Singh G.D., Youssouf M.S., Dhar K.L., Suri O.P., Suri K.A., Satti N.K., Gupta B.D. and Qazi G.N., Synthesis and bronchodilator activity of new quinazoline derivatives, Eur. J. Med. Chem., 2006, 41, 429-434.
17. Laddha S.S., Wadodkar S.G. and Meghal S.K., CAMP-dependent phosphodiesterase inhibition and SAR studies on novel 6, 8-disubstituted 2-phenyl-3-(substituted benzothiazole-2-yl)-4[3H] quinazolinone, Med. Chem. Res., 2009, 18, 268-276.
18. Alagarsamy V., Solomon V.R. and Dhanabal K., Synthesis and pharmacological evaluation of some 3-phenyl-2-substituted-3H- quinazolin-4-one as analgesic, anti-inflammatory agents" Bioorg. Med. Chem., 2007, 15, 235-241.
19. Alagarsamy V. and Murugesan S., Synthesis and pharmacological evaluation of some 3-(4-methoxyphenyl)-2-substituted amino- quinazolin- 4(3H)-ones as analgesic and anti-inflammatory agents, Chem. Pharma. Bull., 2007, 55(1), 76-80.
20. Alagarsamy V., Shankar D., Solomon V.R., Sheorey R.V. and Parthiban P., Synthesis and pharmacological evaluation of some 3-cyclohexyl- 2-substituted hydrazino-3H-quinazolin-4-one as analgesic and anti-inflammatory agents, Acta. Pharma., 2009, 59, 75-88.
21. Alagarsamy V., Solomon V.R., Sheorey R.V. and Jayakumar R., 3-(3-Ethyphenyl)-2-substituted hydrazine-3H-quinazolin-4-one derivatives: new class of analgesic and anti-inflammatory agents, Chem. Biol. Drug Des., 2009, 73, 471-479.
22. Alagarsamy V., Solomon V.R., Murugan M., Sankaranarayanan R., Periyasamy P., Deepa R. and Anandkumar T.D., Synthesis of 3-(2-pyridyl)- 2-substituted-quinazolin-4(3H)-ones as new analgesic and anti-inflammatory agents" Biomed. Pharmacotherapy, 2008, 62, 454-461.
23. Giri R.S., Thaker H.M., Giordano T., Williams J., Rogers D., Sudersanam V. and Vasu K.K., Design, synthesis and characterization of novel 2-(2, 4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline- 4-one derivatives as inhibitors of NF-κB and AP-1 mediated transcription activation and as potential anti-inflammatory agents, Eur. J. Med. Chem., 2009, 44, 2184-2189.
24. Kumar A. and Rajput C.S., Synthesis and antiinflammatory activity of newer quinazoline-4-one derivatives, Eur. J. Med. Chem., 2009, 44, 83-90.
25. Coa S.L, Guuo Y.W., Wang X.B., Zhang M., Feng Y.P., Jiang Y.Y., Wang Y., Gao Q. and Ren J., Synthesis and cytotoxic screening of piperazine-1-carbodithioate derivatives of 2-substituted quinazoline-4(3H)-ones, Arch. Pharm. Chem. Life Sci., 2009, 342, 182-189.
26. Hattori K., Kido Y., Yamampto H., Ishida J., Iwashita A and Mihara K., Rational design of conformationally restricted quinazolinone inhibitors of poly (ATP-ribose) polymerase, Bioorg. Med. Chem. Lett., 2007, 17, 5577-5581.
27. Orvieto F., Branca D., Giomini C., Jones P., Koch U., Ontoria J.M., Palumbi M.C., Rowley M., Toniatti C. and Muragliar E., Identification of substituted pyrazolo[1, 5-a]quinazoline-5(4H)-one as potent poly (ATP=ribose) polymerase=1 (PARP=1), Bioorg. Med. Chem. Lett., 2009, 19, 4196-4200.
28. Converso A., Hartingh T., Garbaccio R.M., Tasber E., Richert K., Fraley M.E., Youwei Y., Kreatsoulas C., Stirdivant S., Drakas B., Walsh E.S.S., Kelly H., Carolyn B.A., Xianzhi M., Marc A.T., Stephen B.C., Weikang T., Rob L., Laura S.L., Joan Z.M., Vinod S., Sanjeev M.K., Sylvie J.S.M., Paul Z.D. and Hartman G.D., Development of thioquinazolinones, allosteric Chk1 kinase inhibitors, Bioorg. Med. Chem. Lett., 2009, 19, 1240-1244.
29. Al-Obaid A.M., Abdel-Hamide S.G., El-Kashef H.A., Abdel-Aziz A.A.M., El-Azab A.S., Al-Khamees H.A., El-Subbagh H.I., Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)- quinazolinone analogs, Eur. J. Med. Chem., 2009, 44, 2379-2391.
30. Raghavendra N.M., Gurubasavarajaswamy P.M., Nagarana-vile K.S. and Parameshwarn T., Antitumor action of imidazolyl-(4-oxoquinazolin- 3-(4H)-yl)-acetamides against Ehrlich Ascites Carcinoma, Arch. Pharm. Res., 2009, 32(3), 431-436.
31. Cipak L., Repicky A. and Jantova S., Growth inhibition and apoptosis induced by 2-phenoxymethyl-3H-quinazolin-4-one in HL-60 leukemia cells" Exp. Oncol. 29, 2007, 1, 13-17.
32. Abhinit M., Ghodke M. and Pratima N.A., Exploring potential of 4-thiazolidinone: a brief review, Int. J. Pharm. Pharm. Sci., 20091, 47-64.
33. Verma A., and S. K. Saraf, "4-Thiazolidinone-a biological active scaffold" Eur. J. Med. Chem., 200843, 897-905.
34. Abdel-Rahman T.M., Reactivity of 3-amino-3Hquinazolin- 4-one derivatives towards some electrophilic and nucleophilic reagents and using of the products in the building of some interesting heterocycles as anticancer agent" J. Heterocyclic. Chem., 2006 43, 527-534.
35. Alagarsamy V., Shankar D., Murugan M., Siddiqui A.A. and Rajesh R., Synthesis and pharmacological evaluation of some 3-(4-methylphenyl)-2-substituted amino-3Hquinazolin- 4-ones as analgesic and antiinflammatory agents, Arch. Pharm. Chem. Life Sci., 2007, 340, 41-46.
36. Baker B.R. and Hurlbut J.A., Irreversible enzyme inhibitors. Proteolytic enzymes. Tolerance for polar groups on the phenoxyacetanilide type of inhibitors of α-chymotrypsin, J. Med. Chem., 196811(5), 1054-1059.
37. Shishoo C.J., Shirsath V.S., Rathod I.S. and Yande V.D., Design, Synthesis and Antihistaminic (H1) Activity of Some Condensed 3-Aminopyrimidin- 4(3H)-ones. Eur. J. Med. Chem., 2000, 35, 351-358.
38. Desal N.C., Bhavsar A.M. and Baldaniya B.B., Synthesis and antimicrobial activity of 5-imidazolinone derivatives, Indian J. Pharm. Chem., 2009, 71(1), 90-94.
39. Kambe S., Saito K. and Kishi H., A one-step synthesis of 4-oxo-2-thioxopyrimidine derivatives by the ternary condensation of ethyl cyanoacetate, aldehydes, and thiourea, Synthesis, 1979, 287-289.
40. Skehan P., Storeng R., Scudiero D., Monks A, McMahon J., Visitica D., Warren J.T, Bokesch H., Kenney S. and Boyd R.M., New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer Inst., 1990, 82, 1107-1112.
41. Winter C.A., Risely E.A., Nuss G.W., Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatorydrugs, Proc. Soc. Exp. Biol. Med., 1962, 111, 544-547.
42. Barsoum F.F., Hosni H.M. and Girgis A.S., Novel Bis(1-acyl-2-pyrazolines) of Potential Antiinflammatory and Molluscicidal Properties., Bioorg. Med. Chem. 2006, 14, 3929-3937.
43. Hamza Y.E., Sammour O.A. and Abdel-Latif H.A., Enhancement of Dissolution of Indometacin and Modulation of Its Pharmacodynamics and Ulcerogenicity via Solid Dispersions., Pharm. Ind., 1994, 56, 286-291.
44. Ram V.J., Vanden Berghe D.A. and Vlientinck A.J., "5-Cyano-6-aryluracil and 2-thiouracil derivatives as potential chemotherapeutic agents" J. Heterocyclic chem., 1984, 21, 1307-1312.
45. Ram V.J., Goel A., Nath M. and Srivastava P., 5-cyano-2 thiouracils and their derivatives: A new class of leishmanicides, Bioorg. Med. Chem. Lett., 1994, 4(22), 2653-2656.
46. Ram V.J., Vanden Berghe D.A. and Vlientinck A.J., Synthesis and activities of novel pyrimidines derived from 5-cyano-6-aryl-2-thiouracil", Liebigs Ann. Chem., 1987, 797-801.
47. Abdou I.M., Strekowski L., A facile synthesis of 6-aryl-5-cyano-1-(β-D-pyranosyl or β-Dfuranosyl)- 2-thiocytosines, Tetrahedron., 2000, 56, 8631-836,.
48. Balalaie S., Bararganian M. and Rominger F., An efficient one-pot synthesis of 6-aryl-5-cyano-2-thiopyrimidinone derivatives and their piperidinium ionic forms, X-ray crystal structures, J. Heterocyclic Chem., 2006, 43, 821-826.